Psychiatrist/PMHNP (Greenbrook)-Leominster
Leominster, Massachusetts, United States of America
Contract
2 days ago
$350,000 - $446,000 USD
Key skills
CLeadership
About this role
About Neuronetics
Neuronetics is a medical technology company focused on designing, developing, and marketing products that improve quality of life for patients suffering from psychiatric disorders. Neuronetics’ NeuroStar® Advanced Therapy is today’s leading TMS (transcranial magnetic stimulation) technology and was the first TMS system designed for clinical use in the treatment of people with major depressive disorder (MDD).
Each day, we remain committed to our mission and values. We have passion for purpose and work with integrity, fearlessness, respect, and as a unified team. If you are driven, take initiative, want to enjoy what you do, and positivity is your middle name, we are interested in hearing from you!
Achieve TMS Centers East, P.C. (a division of Greenbrook TMS NeuroHealth Centers Services, LLC)
IS SEEKING A FULL-TIME BOARD CERTIFIED & BOARD ELIGIBLE PSYCHIATRIST FOR ON SITE TMS TREATMENT AND TO EXPAND SPRAVATO® PROGRAM IN LEOMINSTER, MA
Greenbrook now operates 95 centers throughout the United States with a focus on specialized services for treatment-resistant depression, OCD, and other mental health disorders.
WHY JOIN?
- Expand your professional knowledge & clinical skillset
- Make a difference in the lives of patients using innovative treatment options
- Enjoy flexibility with respect to scheduling (no nighttime, weekend, or on call hours)
- Benefit from an additional income opportunity with competitive pay
- Receive specialized TMS certification and training
- Work alongside our experienced management & clinical leadership team
- Competitive pay PLUS a generous benefits package including 401(k) with company match, paid time off, medical/dental/vision coverage, and a variety of voluntary ancillary plan options
Operating through 130 Company-operated treatment centers, Greenbrook is a leading provider of Transcranial Magnetic Stimulation ("TMS") therapy and Spravato® (esketamine nasal spray), FDA-cleared, non-invasive therapies for the treatment of Major Depressive Disorder ("MDD") and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Spravato® is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. Greenbrook has provided more than 1.3 million treatments to over 40,000 patients struggling with depression.
Over 16 million Americans are affected by depression. Greenbrook TMS is changing the way that depression is treated, and YOU can be part of making a positive difference in the lives of patients by joining our amazing team!
To learn more about our WHY, click here: https://youtu.be/yrr-wlFftT0
For patient testimonies on HOW we are transforming lives for the better, click here: https://www.greenbrooktms.com/patient-stories
To access provider information, click here: https://www.greenbrookproviders.com
GBSP25